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The central role played by high density lipoproteins (HDLs) in reverse cholesterol 
transport has been studied in details over the past years. One of the many functions 
of HDLs is to facilitate the uptake of cholesterol from cells of peripheral organs and to 
deliver it to the liver where it is transferred to the bile for excretion. Scavenger 
receptor class B type 1 (SRB1), which is abundantly expressed in the liver, 
participates in the selective hepatic cholesterol uptake from mature HDL particles [1]. 
A second recently discovered pathway involves HDL particle uptake by the P2Y13 
purinergic receptor [2]. How SRB1 binds to HDLs and unload its cholesterol cargo 
remains to be precisely determined, as different mechanisms have been proposed, 
implicating or not HDL particle endocytosis [3, 4]. 
The experiments studying the implication of SRB1 in reverse cholesterol transport 
have so far always considered that this occurs in hepatocytes. In our current 
understanding of reverse cholesterol transport, liver sinusoidal endothelial cells 
(LSECs) act as a hedgerow separating blood circulation from the space of Disse (the 
extracellular space located between endothelial cells and hepatocytes), allowing 
HDLs to passively move from the circulation to the hepatocytes where their 
cholesterol cargo is processed [5]. Given the known high capacity of LSECs to 
scavenge many different particles, Ganesan and colleagues evaluated the 
participation of these cells in HDL metabolism in a study recently published in 
Scientific Reports [6]. Using two different approaches (high-resolution confocal 
microscopy of ultrathin section of mouse liver and flow cytometry of purified cell 
populations), they convincingly conclude that LSECs express substantially more 
SRB1 than hepatocytes. They explain the discrepancy between their findings and 
what has been described so far in the literature by technical limitations of earlier 
approaches. 
If hepatocytes really express almost no SRB1, how do HDLs enter hepatocytes to be 
metabolized and how is cholesterol eventually secreted into the bile? Different routes 
are possible. Ganesan and colleagues do not exclude that a very small amount of 
SRB1, not detectable with current technologies, is present on hepatocytes and 
mediates the interaction with HDLs. Alternatively, other HDL receptors might mediate 
the uptake of HDLs in hepatocytes, such as CD36 or P2Y13 [2, 7]. Another 
possibility is that HDLs captured by the SRB1-bearing LSECs is made available to 
the hepatocytes by a mechanism involving transcytosis. Similar mechanisms have 
been observed in other endothelial cells [8, 9]. Whether HDLs that bind to SRB1 
expressed on LSECs transcytose as intact molecules or whether unloading of 
cholesterol already happens in LSECs and only cholesterol is then transferred to 
hepatocytes remains to be investigated. 
Mice and humans are quite different in their lipoprotein metabolism [10]. In mice, 
cholesterol is mainly transported by HDLs whereas in humans LDLs fulfil this 
function. This difference comes from the presence of the cholesterol ester transfer 
protein, present in humans and absent in mice, which allows the transfer of 
cholesterol from HDLs to LDLs. These species differences highlight the importance 
of conducting a study on human samples similar to the one mentioned here on SRB1 
expression in hepatocytes and LSECs. 
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